§ 53-10-308. Release of Confidential Information
Notwithstanding this part to the contrary, the committee or the commissioner: May release confidential information from the database regarding healthcare practitioners, healthcare practitioner delegates, or patients to department personnel engaged in an investigation, adjudication, or prosecution of a violation under any state or federal law that involves a controlled substance; May release confidential information from […]
§ 53-10-309. Reports
The commissioner or commissioner’s designee shall report annually on the outcome of the program with respect to its effect on distribution and abuse of controlled substances, including recommendations for improving control and prevention of diversion of controlled substances in this state. The committee, its designee, or the commissioner shall also file an annual report with […]
§ 53-10-310. Practice Sites Where a Controlled Substance Dispensed Required to Provide for Electronic Access to the Controlled Substance Database — Exceptions — Violations and Penalties
Each person or entity operating a practice site where a controlled substance is prescribed or dispensed to a human patient shall provide for electronic access to the database at all times when a healthcare practitioner provides healthcare services to a human patient potentially receiving a controlled substance. This section shall not apply to any person […]
§ 53-10-311. Establishment of Operations Committee — Agreements With Federal Government and Other Jurisdictions for Sharing and Dissemination of Data and Information
There is created an operations committee. The committee shall be composed of: The board of medical examiners’ medical director for special projects; An epidemiologist employed by the department of health; The executive director of the board of pharmacy; The director of the controlled substance database; A member of the controlled substance database committee; The executive […]
§ 53-10-312. Minimum Reporting Requirements for Wholesalers and Manufacturers — Establishment of Rules as to Reporting Requirements
Wholesalers and manufacturers, as defined in § 63-10-204, that sell controlled substances at wholesale must at least report the following information to the committee in Automation of Reports and Consolidated Orders System (ARCOS) format or other mutually acceptable format: Wholesaler or manufacturer with a drug enforcement administration registration number; provided, that if this number is […]
§ 53-10-401. Tamper-Proof Prescriptions
All prescriptions written or printed by practitioners authorized to write prescriptions in this state shall be written on either tamper-resistant prescription paper or printed utilizing a technology that results in a tamper-resistant prescription that meets the current centers for medicare and medicaid services guidance to state medicaid directors regarding § 7002(b) of the United States […]
§ 53-10-303. Controlled Substance Database Committee. [Effective Until July 1, 2023. See Version Effective on July 1, 2023.]
There is created the controlled substance database committee. The committee members shall be: One (1) of the governor-appointed licensed members of each of the following healthcare professional licensure boards or committees to be chosen by the licensing board or committee: The board of medical examiners; The board of osteopathic examination; The board of dentistry; The […]
§ 53-10-303. Controlled Substance Database Committee. [Effective on July 1, 2023. See Version Effective Until July 1, 2023.]
There is created the controlled substance database committee. The committee members shall be: One (1) of the governor-appointed licensed members of each of the following healthcare professional licensure boards or committees to be chosen by the licensing board or committee: The board of medical examiners; The board of osteopathic examination; The board of dentistry; The […]
§ 53-10-304. Controlled Substance Database — Director — Administration — Requirements
There is created within the department a controlled substance database. The director of the controlled substance database shall be responsible for determining staffing in consultation with the executive director of the board of pharmacy. The director shall administer, maintain, and direct the functioning of the database in accordance with this part. The department in consultation […]
§ 53-10-305. Submission of Information — Data Format
All healthcare practitioners who prescribe or dispense controlled substances in practice providing direct care to patients in this state by prescribing or dispensing on more than fifteen (15) days in a calendar year total and are required to have a federal drug enforcement administration (DEA) registration pursuant to federal law shall be registered in the […]